Enliven Therapeutics, Inc.

General ticker "ELVN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.2B (TTM average)

Enliven Therapeutics, Inc. follows the US Stock Market performance with the rate: 32.2%.

Estimated limits based on current volatility of 3.2%: low 40.80$, high 43.49$

Factors to consider:

  • Earnings expected soon, date: 2026-05-13 bmo
  • Total employees count: 46 as of 2023
  • Current price 72.3% above estimated high

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [10.30$, 24.21$]
  • 2026-12-31 to 2027-12-31 estimated range: [8.78$, 21.05$]

Financial Metrics affecting the ELVN estimates:

  • Negative: with PPE of -8.8 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -7.57 <= 0.07
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Shareholder equity ratio, % of 96.52 > 64.25
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term ELVN quotes

Long-term ELVN plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $83.53MM $104.55MM $119.66MM
Operating Income $-83.53MM $-104.55MM $-119.66MM
Non-Operating Income $11.95MM $15.76MM $15.96MM
R&D Expense $64.57MM $80.78MM $85.86MM
Income(Loss) $-71.58MM $-88.79MM $-103.69MM
Taxes $0.00MM $0.23MM $0.00MM
Profit(Loss)* $-71.58MM $-89.02MM $-103.69MM
Stockholders Equity $245.91MM $309.85MM $459.60MM
Assets $271.87MM $325.76MM $476.17MM
Operating Cash Flow $-61.27MM $-73.19MM $-70.30MM
Capital expenditure $0.15MM $0.04MM $0.16MM
Investing Cash Flow $-148.41MM $-36.00MM $-173.84MM
Financing Cash Flow $234.29MM $133.16MM $218.87MM
Earnings Per Share** $-2.01 $-1.89 $-1.83

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.